In each of our areas of focus, we work with an array of partners, including government agencies in high-burden and donor countries, multilateral organizations, nongovernmental organizations, academic institutions, community organizations, and private industry. We also work to ensure that adequate funding and appropriate global and national-level policies are in place to support HIV prevention and treatment efforts, research and development, and efforts to understand the motivations and needs of high-risk populations.
Improving Diagnosis and Expanding Treatment Coverage
About half of all people living with HIV, particularly men, do not know they have the virus. We support the development and appropriate use of novel tools that can greatly increase the number of people who know their status and who seek treatment.
Improving Treatment Retention
HIV treatment programs are often expensive and inflexible, leading many individuals living with HIV to discontinue the treatment they need. We support partners who are working to simplify the delivery of HIV treatment and introduce models of care that are more tailored to the needs of particular populations and their circumstances. Better patient data systems are also crucial to keeping people living with HIV on effective treatment.
HIV-related information is displayed in a waiting area outside a rural clinic in Kivumu, Rwanda.
Viral load testing—the measuring of HIV particles in the blood—can be crucial to helping people living with HIV understand their health status and be motivated to continue treatment. We support the improved use of viral load testing, as well as the development of novel virus load-testing systems, as a means of sustaining effective treatment.
Expanding the Use of Existing Preventive Measures
Several existing measures have proven effective in preventing HIV infection. They include voluntary medical male circumcision, condoms, and drugs that reduce the risk of acquiring the virus after exposure. These measures can be effective only if they are affordable and reach high-risk populations—and only if those populations are aware of their risk of contracting HIV.
Widespread voluntary medical male circumcision could play a major role in limiting the spread of HIV, and efforts by global partners have greatly improved access to and demand for circumcision. We support circumcision-related efforts in several high-burden countries in Sub-Saharan Africa.
We also support efforts to improve consistent condom use and the use of drugs that reduce the risk of contracting HIV. In addition, understanding and addressing the obstacles to accessing and using these measures among high-risk populations is central to our overall prevention strategy.
Developing Long-Acting Prevention Measures
New, more effective prevention methods are essential to reducing HIV transmission. We support efforts to develop, evaluate, and introduce innovative approaches to protecting those at risk. These include potential long-acting prevention interventions that can provide continuous protection over a period of time.
Developing an HIV Vaccine
We continue to invest in efforts to develop an HIV vaccine. Although developing a highly effective vaccine remains a substantial scientific challenge, even a vaccine with partial efficacy and limited duration could help dramatically reduce the global incidence of HIV.